Business & regional news

Month Year

Month Year

Oct 23, 2025

Medtronic announces new clinical milestones spanning coronary, renal denervation and structural heart businesses at TCT 2025
- Coronary and Renal Denervation
Sep 25, 2025

Symplicity Blood Pressure Procedure Spotlighted as Another Solution for Uncontrolled Hypertension at Fourth High-level Meeting of the UN General Assembly
- Coronary and Renal Denervation
Sep 2, 2025

Medtronic receives approval for Symplicity Spyral™ Renal Denervation System in Japan

Japan is now the 77th country to receive regulatory approval for the Symplicity Spyral Renal Denervation System
- Coronary and Renal Denervation
Aug 14, 2025

Medtronic announces 2025 American College of Cardiology / American Heart Association updated hypertension guidelines for renal denervation; procedure now recommended
- Coronary and Renal Denervation
Jul 10, 2025

Medtronic issues statement on the U.S. Centers for Medicare & Medicaid Services proposed National Coverage Determination for Symplicity Spyral™ renal denervation (RDN) system
- Coronary and Renal Denervation
Jul 7, 2025

First patient treated in Medtronic multi-organ SPYRAL GEMINI Pilot study

Medtronic advances pipeline with update on multi-organ denervation study and additional data recently presented at EuroPCR 2025
- Coronary and Renal Denervation
Jun 11, 2025

Medtronic treats first U.S. patient in Global SYMPLICITY Registry DEFINE Study

Large, international registry designed to expand real-world data for Symplicity blood pressure procedure for uncontrolled hypertension
- Coronary and Renal Denervation
May 22, 2025

Medtronic receives expanded CE Mark indications for Prevail™ paclitaxel-coated PTCA balloon catheter, including complex bifurcation lesions

Medtronic, a global leader in healthcare technology, announced today that it has received CE (Conformité Européenne) Mark approval for several expanded indications for the treatment of coronary...
- Coronary and Renal Denervation
- Photos 1
Mar 8, 2025

Medtronic Prevail™ paclitaxel-coated balloon catheter shows positive performance in Swedish Coronary Angiography and Angioplasty Registry

Data from the largest study comparing drug-coated balloons presented as a late-breaking clinical trial at Cardiovascular Research Technologies 2025
- Coronary and Renal Denervation
Feb 26, 2025

Medtronic enrolls first patient in global trial for its Prevail™ drug-coated balloon

St. Francis Hospital in New York performs the first patient procedure in clinical trial for coronary artery disease
- Coronary and Renal Denervation

Show per page